← FDA DRUG APPROVALS

FDA NDA · NDA019127

DYNA-HEX 4

chlorhexidine gluconate

Sponsor: XTTRIUM

APPLICATION
NDA019127
TYPE
NDA
ORIGINAL APPROVAL
1984-12-24
LATEST ACTION
2025-05-27
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, METERED
MARKETING STATUS
Over-the-counter

Products

EXIDINE · ReferenceOver-the-counter
CHLORHEXIDINE GLUCONATE 4% · AEROSOL, METERED · TOPICAL

Approval history

2025-05-27Labeling · Supplement 27 · standardLetterAP
2017-09-14Labeling · Supplement 22 · standardLetterAP
2013-04-11Labeling · Supplement 20 · standardLetterAP
2012-07-11Manufacturing (CMC) · Supplement 17 · standardAP
2009-06-16Manufacturing (CMC) · Supplement 13LetterAP
1997-06-30Manufacturing (CMC) · Supplement 10 · standardAP
1996-04-12Manufacturing (CMC) · Supplement 9 · standardAP
1996-02-13Manufacturing (CMC) · Supplement 8 · standardAP
1995-06-19Manufacturing (CMC) · Supplement 7 · standardAP
1995-06-19Manufacturing (CMC) · Supplement 6 · standardAP
1994-12-15Manufacturing (CMC) · Supplement 5 · standardAP
1988-06-28Manufacturing (CMC) · Supplement 2 · standardAP
1988-03-02Manufacturing (CMC) · Supplement 1 · standardAP
1984-12-24Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →